Givaudan’s Q2 2026: Organic Sales Surge 3.6%, Margins Erode – What It Means for Investors
Givaudan’s H1 2026 shows accelerated organic growth of 3.6%, but margin and cash‑flow pressures weigh on earnings, prompting a 5.8% share drop.
3 minutes to read